Literature DB >> 24361628

HIV-exposed infants: rethinking care for a lifelong condition.

Nandita Sugandhi1, Jessica Rodrigues, Maria Kim, Saeed Ahmed, Anouk Amzel, Mike Tolle, Eric J Dziuban, Scott E Kellerman, Emilia Rivadeneira.   

Abstract

Each year over a million infants are born to HIV-infected mothers. With scale up of prevention of mother-to-child transmission (PMTCT) interventions, only 210 000 of the 1.3 million infants born to mothers with HIV/AIDS in 2012 became infected. Current programmatic efforts directed at infants born to HIV-infected mothers are primarily focused on decreasing their risk of infection, but an emphasis on maternal interventions has meant follow-up of exposed infants has been poor. Programs are struggling to retain this population in care until the end of exposure, typically at the cessation of breastfeeding, between 12 and 24 months of age. But HIV exposure is a life-long condition that continues to impact the health and well being of a child long after exposure has ended. A better understanding of the impact of HIV on exposed infants is needed and new programs and interventions must take into consideration the long-term health needs of this growing population. The introduction of lifelong treatment for all HIV-infected pregnant women is an opportunity to rethink how we provide services adapted for the long-term retention of mother-infant pairs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24361628      PMCID: PMC4089095          DOI: 10.1097/QAD.0000000000000090

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  48 in total

1.  Time for new recommendations on cotrimoxazole prophylaxis for HIV-exposed infants in developing countries?

Authors:  Anna Coutsoudis; Hoosen M Coovadia; Gurpreet Kindra
Journal:  Bull World Health Organ       Date:  2010-12-01       Impact factor: 9.408

2.  The first months of life: a critical period for development of obesity.

Authors:  Matthew W Gillman
Journal:  Am J Clin Nutr       Date:  2008-06       Impact factor: 7.045

3.  Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America.

Authors:  Lynne M Mofenson; James Oleske; Leslie Serchuck; Russell Van Dyke; Cathy Wilfert
Journal:  Clin Infect Dis       Date:  2005-02-01       Impact factor: 9.079

4.  In utero exposure to tenofovir disoproxil fumarate does not impair growth and bone health in HIV-uninfected children born to HIV-infected mothers.

Authors:  Alessandra Viganò; Stefano Mora; Vania Giacomet; Sara Stucchi; Valeria Manfredini; Clara Gabiano; Filippo Salvini; Monica Cellini; Enrica Tamburrini; Maria Puzzovio; Gian Vincenzo Zuccotti
Journal:  Antivir Ther       Date:  2011

5.  Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy.

Authors:  Kunjal Patel; David E Shapiro; Susan B Brogly; Elizabeth G Livingston; Alice M Stek; Arlene D Bardeguez; Ruth E Tuomala
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

6.  [Congenital cytomegalovirus infection in the infants of HIV-infected mothers].

Authors:  M A Marín Gabriel; M Fernández Ibieta; María I González Tomé; J Saavedra Lozano; V Barajas Sánchez; P Rojo Conejo; J T Ramos Amador
Journal:  An Pediatr (Barc)       Date:  2005-01       Impact factor: 1.500

7.  Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women.

Authors: 
Journal:  J Acquir Immune Defic Syndr       Date:  2003-04-01       Impact factor: 3.731

8.  Impact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in Sub-Saharan Africa: a cohort study.

Authors:  Landon Myer; Rosalind J Carter; Monica Katyal; Patricia Toro; Wafaa M El-Sadr; Elaine J Abrams
Journal:  PLoS Med       Date:  2010-02-09       Impact factor: 11.069

9.  High human cytomegalovirus loads and diverse linked variable genotypes in both HIV-1 infected and exposed, but uninfected, children in Africa.

Authors:  M Bates; M Monze; H Bima; M Kapambwe; F C Kasolo; U A Gompels
Journal:  Virology       Date:  2008-10-16       Impact factor: 3.616

10.  Barriers to Initiation of Pediatric HIV Treatment in Uganda: A Mixed-Method Study.

Authors:  T Sonia Boender; Kim C E Sigaloff; Joshua Kayiwa; Victor Musiime; Job C J Calis; Raph L Hamers; Lillian Katumba Nakatudde; Elizabeth Khauda; Andrew Mukuye; James Ditai; Sibyl P Geelen; Peter Mugyenyi; Tobias F Rinke de Wit; Cissy Kityo
Journal:  AIDS Res Treat       Date:  2012-02-06
View more
  16 in total

1.  Neurodevelopment of HIV-Exposed and HIV-Unexposed Uninfected Children at 24 Months.

Authors:  Sumona Chaudhury; Paige L Williams; Gloria K Mayondi; Jean Leidner; Penny Holding; Vicki Tepper; Sharon Nichols; Jane Magetse; Maureen Sakoi; Kebaiphe Moabi; Joseph Makhema; Charlotte Mdluli; Haruna Jibril; George R Seage; Betsy Kammerer; Shahin Lockman
Journal:  Pediatrics       Date:  2017-09-14       Impact factor: 7.124

2.  Complementary Feeding and Diarrhea and Respiratory Infection Among HIV-Exposed Tanzanian Infants.

Authors:  Pili Kamenju; Enju Liu; Ellen Hertzmark; Donna Spiegelman; Rodrick R Kisenge; Roland Kupka; Said Aboud; Karim Manji; Christopher Duggan; Wafaie W Fawzi
Journal:  J Acquir Immune Defic Syndr       Date:  2017-03-01       Impact factor: 3.731

3.  Quality of Caregiving is Positively Associated With Neurodevelopment During the First Year of Life Among HIV-Exposed Uninfected Children in Uganda.

Authors:  Itziar Familiar; Shalean M Collins; Alla Sikorskii; Horacio Ruisenor-Escudero; Barnabas Natamba; Paul Bangirana; Elizabeth M Widen; Daniel Achidri; Harriet Achola; Daniel Onen; Michael Boivin; Sera L Young
Journal:  J Acquir Immune Defic Syndr       Date:  2018-03-01       Impact factor: 3.731

4.  Determinants of growth in HIV-exposed and HIV-uninfected infants in the Kabeho Study.

Authors:  Charlotte E Lane; Emily A Bobrow; Diuedonne Ndatimana; Gilles F Ndayisaba; Linda S Adair
Journal:  Matern Child Nutr       Date:  2019-01-29       Impact factor: 3.092

5.  Nutritional status and complementary feeding among HIV-exposed infants: a prospective cohort study.

Authors:  Pili Kamenju; Enju Liu; Ellen Hertzmark; Donna Spiegelman; Rodrick Kisenge; Roland Kupka; Said Aboud; Karim P Manji; Christopher Duggan; Wafaie W Fawzi
Journal:  Matern Child Nutr       Date:  2016-09-30       Impact factor: 3.092

6.  New Directions for the Consideration of HIV: Heterogeneity and the Cognition of Time.

Authors:  Mei Tan
Journal:  New Dir Child Adolesc Dev       Date:  2020-01

7.  The influence of HIV and schistosomiasis on renal function: a cross-sectional study among children at a hospital in Tanzania.

Authors:  Neema M Kayange; Luke R Smart; Jennifer A Downs; Mwanaisha Maskini; Daniel W Fitzgerald; Robert N Peck
Journal:  PLoS Negl Trop Dis       Date:  2015-01-22

8.  Impact of elevated maternal HIV viral load at delivery on T-cell populations in HIV exposed uninfected infants in Mozambique.

Authors:  Nilsa de Deus; Cinta Moraleda; Celia Serna-Bolea; Montse Renom; Clara Menendez; Denise Naniche
Journal:  BMC Infect Dis       Date:  2015-02-03       Impact factor: 3.090

9.  The Danish HIV Birth Cohort (DHBC) - a nationwide, prospective cohort.

Authors:  Nina Weis; Terese L Katzenstein; Mathilde Ørbæk; Merete Storgaard; Gitte Pedersen; Isik S Johansen; Ellen Moseholm
Journal:  BMJ Open       Date:  2021-07-08       Impact factor: 2.692

10.  Outcomes of HIV-exposed but uninfected children in South Africa over 5 years.

Authors:  Mary J Rotheram-Borus; Adriane Wynn; Jackie Stewart; Ellen Almirol; Thomas W Weichle; Julia Tubert; Mark Tomlinson
Journal:  AIDS       Date:  2021-02-02       Impact factor: 4.632

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.